
==== Front
ACS OmegaACS OmegaaoacsodfACS Omega2470-1343American Chemical Society 3145733910.1021/acsomega.7b01391ArticleTandem Double [3 + 2] Cycloaddition Reactions at Both
C-1 and C-3 Atoms of N-Cyanomethylisoquinolinium
Ylide Shi Rong-Guo Sun Jing Yan Chao-Guo *College of Chemistry &
Chemical Engineering, Yangzhou University, Yangzhou 225002, China* E-mail: cgyan@yzu.edu.cn.13 11 2017 30 11 2017 2 11 7820 7830 18 09 2017 01 11 2017 Copyright © 2017 American Chemical Society2017American Chemical SocietyThis is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.

The base-promoted
cycloaddition reaction of N-cyanomethylisoquinolinium
chloride with 2-arylidene-1,3-indanediones in dry tetrahydrofuran
resulted in the expected spiro[indene-2,1′-pyrrolo[2,1-a]isoquinoline] derivatives. However, the triethylamine-promoted
three-component reaction of N-cyanomethylisoquinolinium
chloride, aromatic aldehydes, and two molecules of 1,3-indanediones
in acetonitrile afforded unique spiro[benzo[f]imidazo[5,1,2-cd]indolizine-4,2′-indene] derivatives in satisfactory
yields through tandem double [3 + 2] cycloaddition reactions.

document-id-old-9ao7b01391document-id-new-14ao-2017-01391yccc-price
==== Body
Introduction
As one of the reactive
heteroaromatic N-ylides,
isoquinolinium ylides have been attracting continuous attention due
to their easy preparation and versatile reactivity and become one
of the most valuable synthons for the construction of nitrogen-containing
heterocyclic systems.1,2 Isoquinolinium ylides can be conveniently
generated in situ from deprotonation of the corresponding N-substituted methylisoquinolinium salts in basic media.3 The most common reaction of isoquinolinium ylide
is the [3 + 2] cycloaddition reaction with various 1,3-dipolarophiles
to give pyrrolo[2,1-a]isoquinoline derivatives (eq
1 in Scheme 1).4 By employing various substrates and adopting
different reaction conditions, these kinds of reactions have resulted
in many pyrrolo[2,1-a]isoquinoline derivatives and
related spiro or polycyclic systems with valuable molecular diversity
and regulated diastereoselectivity.5 In
recent years, new synthetic reaction patterns of isoquinolinium ylides
have been successfully revealed, which indicated that there are many
unknown characters in the chemistry of isoquinolinium ylides.6 For examples, the base-promoted reaction of N-phenacylisoquinolinium ylides with arylidene Meldrum acid
resulted in stable zwitterionic salts.7a More notably, the isoquinolinium zwitterionic salts with an unusual
C-4 substitution pattern were also obtained from the reaction of N-benzylisoquinolinium ylides with aromatic aldehydes and
cyclic 1,3-dicarbonyl compounds (eq 2 in Scheme 1).7b The base-mediated
three-component reaction of N-alkoxycarbonylmethylisoquinolinium
salts, aromatic aldehydes, and 1,3-indanedione afforded the unprecedented
complex polycyclic compounds, in which the generated isoquinilonium
ylide not only behaved as a reactive 1,3-dipole but also acted as
a useful diene to accomplish sequential 1,3-dipolar cycloaddition
and the Diels–Alder reaction (eq 3 in Scheme 1).8 In continuation
of our aim to exploit the potential synthetic applications of the
heteroaromatic N-ylides,8 herein, we wish to reveal the unprecedented reactions of N-cyanomethylisoquinolinium chloride with 2-arylidene-1,3-indanediones
under different reaction conditions. The reaction not only gave the
normal spiro[indene-2,1′-pyrrolo[2,1-a]isoquinoline]
derivatives through the normal 1,3-dipolar cycloaddition reaction
but also afforded unique spiro[benzo[f]imidazo[5,1,2-cd]indolizine-4,2′-indene] derivatives by the domino
cyclization process (eq 4 in Scheme 1).

Scheme 1 Illustration of Typical Reaction Patterns of Isoquinolinium
Ylides
Results and Discussion
Initially, the conditions for the reaction of N-cyanomethylisoquinolinium chloride with 2-benzylidene-1,3-indanedione
were briefly examined on the basis of our previously established reaction
conditions for the N-phenacyl and N-ethoxycarbonylmethylisoquinolinium salts.8 When the reaction was carried out in the solvent of MeOH, EtOH,
CH3CN and dry tetrahydrofuran (THF) in the presence of
triethylamine as base for about 10 h, the expected spiro[indene-2,1′-pyrrolo[2,1-a]isoquinoline], 1a, was obtained in 47, 51,
56, and 81% yields. When 1,4-diazabicyclo[2.2.2]octane (DABCO), 1,8-diazabicyclo[5.4.0]undec-7-ene
(DBU), and piperidine were used as base, the reaction in dry THF gave
45, 59, and 57% yields. When the triethylamine-promoted reaction was
carried out in THF at about 50 °C for 5 h, the yield of product 1a greatly decreased to 31%. Thus, in the presence of slight
excess triethylamine, the reactions of N-cyanomethylisoquinolinium
chloride with various 2-arylidene-1,3-indanediones in dry THF at room
temperature (rt) for about 10 h afforded spiro[indene-2,1′-pyrrolo[2,1-a]isoquinolines] 1a–f in
good yields. The structures of spiro compounds were successfully characterized
by IR, high-resolution mass spectrometry (HRMS), 1H NMR,
and 13C NMR spectra. It should be pointed out that spiro
compounds 1a–f are not very stable
in solution, especially in the protonic solvent or hydrous solvent.
It must be quick to separate samples and record their 1H and 13C NMR spectra. The formation of spiro[indene-2,1′-pyrrolo[2,1-a]isoquinolines] 1a–f obviously
took place from the normal [3 + 2] cycloaddition of the in situ-generated
isoquinolinium ylide with 2-arylidene-1,3-indanediones. The 1H NMR and 13C NMR spectra clearly indicated that only
one diastereoisomer exists in the obtained samples of the products.
On the basis of NMR spectra and previously obtained results, we tentatively
assigned the spiro compounds 1a–f having trans-configuration.

Because 2-arylidene-1,3-indanediones
were initially prepared from
the base-catalyzed condensation of aromatic aldehydes with 1,3-indanedione,
it is natural to test the possibility of converting the above reaction
to a one-pot three-component reaction. When equal amounts of N-cyanomethylisoquinolinium chloride, benzaldehyde, and
1,3-indanedione were stirred in ethanol in the presence of triethylamine,
instead of the formation of above spiro[indene-2,1′-pyrrolo[2,1-a]isoquinoline], a unique spiro[benzo[f]imidazo[5,1,2-cd]indolizine-4,2′-indene] 2a was obtained in 31% yield, in which two scaffolds of 1,3-indanedione
were eventually included in the molecule. When excess 1,3-indanedione
was employed and triethylamine was used as the base, the reaction
in MeOH, EtOH, and CH3CN gave new product 2a in 51, 67, and 83% yields, respectively. When other bases such as
DABCO, DBU, and Na2CO3 were used as the base,
the yield of the product did not increase. Prolonging reaction time
or carrying out the reaction at an elevated temperature also caused
a decrease in yield. Thus, the best conditions for this reaction are
carrying out the reaction in acetonitrile at room temperature in the
presence of triethylamine as the base promoter. Under these convenient
reaction conditions, the reaction scope was investigated, and the
obtained results are summarized in Tables 1 and 2. We were pleased
to find that various aromatic aldehydes with different substituents
reacted smoothly to give spiro polycyclic compounds 2a–o in high yields. Some heterocylic substituted
aldehydes, such as 2-furfural, 2-thiophenecarbaldehyde, picolinaldehyde,
nicotinaldehyde, and isonicotinaldehyde, also gave desired products 2p–t in good yields. n-Heptaldehyde was also successfully employed in the reaction to give
spiro products 2x and 2y in good yields. Phenylglyoxal
also afforded benzoyl-substituted product 2y in 85% yield.
On the other hand, the reaction with substituted isoquinolines such
as 5-bromoisoquinoline also resulted in spiro products 2v and
2w in satisfactory yields. These results indicated that this
reaction has a wide variety of substrates.

Table 1 Synthesis
of Spiro[indene-2,1′-pyrrolo[2,1-a]isoquinolines] 1a–fa
entry	compd	Ar	yield (%)b	
1	1a	C6H5	81	
2	1b	o-CH3OC6H4	84	
3	1c	p-CH3C6H4	79	
4	1d	p-BrC6H4	83	
5	1e	p-ClC6H4	81	
6	1f	p-(t-Bu)C6H4	61	
a Reaction conditions:
isoquinolinium
salt (0.5 mmol), 2-arylidene-1,3-indanedione (0.5 mmol), Et3N (0.6 mmol), THF (15.0 mL), rt, 10 h.

b Isolated yields.

Table 2 Synthesis of Polycyclic Spiro Compounds 2a–ua
entry	compd	R	Ar	yield (%)b	
1	2a	H	C6H5	83	
2	2b	H	o-HOC6H4	78	
3	2c	H	o-CH3OC6H4	87	
4	2d	H	o-ClC6H4	89	
5	2e	H	o-BrC6H4	85	
6	2f	H	m-CH3C6H4	86	
7	2g	H	m-FC6H4	81	
8	2h	H	m-NO2C6H4	82	
9	2i	H	p-CH3C6H4	92	
10	2j	H	p-(CH3)2NC6H4	73	
11	2k	H	p-BrC6H4	87	
12	2l	H	p-ClC6H4	91	
13	2m	H	p-t-C(CH3)3C6H4	81	
14	2n	H	p-NO2C6H4	79	
15	2o	H	2-HO-4-ClC6H3	72	
16	2p	H	2-furan	69	
17	2q	H	2-thiophen	78	
18	2r	H	2-Py	83	
19	2s	H	3-Py	76	
20	2t	H	4-Py	74	
21	2u	H	benzoyl	85	
22	2v	Br	p-ClC6H4	81	
23	2w	Br	p-NO2C6H4	83	
24	2x	H	n-Hex	70	
25	2y	Br	n-Hex	63	
a Reaction
conditions: isoquinolinium
salt (0.5 mmol), aldehyde (0.5 mmol), 1,3-indanedione (1.1 mmol),
Et3N (1.2 mmol), CH3CN (15.0 mL), rt, 8 h.

b Isolated yields.

The structures of spiro compounds 2a–y were successfully determined by various
spectroscopy techniques.
The single-crystal structures of two representative compounds 2i and 2l were successfully determined by the
X-ray diffraction method (Figure 1). From Figures 1 and 2, it can be seen that both C-1
and C-3 atoms of isoquinolinium ylide took part in the reaction. Although
the pyridinium salts sometimes undergo the double [3 + 2] cycloaddition
reaction at both C-1 and C-6 atoms to give novel pyrrolo[2,1,5-cd]indolizine derivatives,10 it
is rare for isoquinolinium salts to undergo such double [3 + 2] cycloaddition
reactions at both C-1 and C-3 atoms of the isoquinoline ring. The
only example is the early report about the formation of benzocyclo[3.2.2]azines
in lower yield from the double [3 + 2] cycloaddition reaction of isoquinolinium
ylide with N-methylmaleimide.11a Another related example is the NHC-catalyzed enantioselective
dearomatizing double Mannich reaction at both C-1 and C-3 atoms of
isoquinolinium salts to give 8-azabicyclo[3.2.1]octane derivatives.11b On the other hand, there are several reports
about the cyano group to take part in the sequential cyclization process
in the reactions of N-cyanomethylpyridinium salts
and N-cyanomethylisoquinolinium salts.12 Here, the normal [3 + 2] cycloaddition at 1,2-positions
of isoquinolinium ylide was replaced by the abnormal [3 + 2] cycloaddition
at 2,3-positions of isoquinolinium ylide and internal cyclization
at the C-1 position. This kind of reaction pattern might be observed
for the first time in the reactions of isoquinolinium ylides. It is
also noticed that this reaction successfully provided a convenient
dearomatizing method for the isoquinoline ring.

Figure 1 Single-crystal structure
of compounds 2i.

Figure 2 Single-crystal structure of compounds 2l.

Although the exact mechanism is not completely
understood at the
present time, a plausible reaction mechanism is proposed on the basis
of the above results and the previously reported reactions (Scheme 2).9−12 First, an isoquinolinium ylide
(A) was generated from deprotonation of N-cyanomethylisoquinolinium salt. In the meantime, 2-arylidene-1,3-indanedione
was also formed from the Knoevenagel condensation of the respective
aromatic aldehyde with 1,3-indanedione in the presence of triethylamine.
Second, a Michael addition of a isoquinolinium ylide (A) to 2-arylidene-1,3-indanedione afforded a zwitterionic intermediate
(B). Third, the intermolecular cyclization resulted in
spiro compound 1 in dry THF. Spiro compound 1 is not very stable and is in equilibrium with the zwitterionic intermediate
(B) in acetonitrile. Then, the nucleophilic addition
of the carbanion of 1,3-indanedione to the cyano group generated an
imine intermediate (C), which in turn added to the cyclic
iminium ion to give a cyclic intermediate (D). Finally,
the intermolecular nucleophilic addition of carbanion to enamine resulted
in polycyclic product 2 with the corresponding protonation
and proton immigration process. Here, the unique dual reactivities
of the cyano group and 1,3-indanedione are the crucial factors for
completing this reaction sequence.

Scheme 2 Proposed Reaction Mechanism
To probe the credibility of
our proposed mechanistic scheme and
shed more light on the formation of polycyclic spiro compounds, further
control experiments were carried out (Scheme 3). First, an equal combination of 1,3-indanedione
and initially prepared 2-arylidene-1,3-indanedione was used in the
three-component reaction, and corresponding spiro compounds 2a, 2f, and 2k were obtained in
very high yields, which clearly indicated that 2-arylidene-1,3-indanedione
was the intermediate in the reaction. Second, the reaction of initially
prepared spiro[indene-2,1′-pyrrolo[2,1-a]isoquinolines] 1 with 1,3-indandione in acetonitrile in the presence of triethylamine
for overnight resulted in polycyclic spiro compounds 2a and 2m in moderate yields, which clearly showed that
spiro[indene-2,1′-pyrrolo[2,1-a]isoquinolines] 1 decomposed to the zwitterionic intermediate (B) in the solution, which is the key intermediate in the above proposed
mechanism.

Scheme 3 Control Experiments
Conclusions
In summary, we have successfully investigated
the base-promoted
cycloaddition reaction of N-cyanomethylisoquinolinium
chloride with 2-arylidene-1,3-indanediones under different reaction
conditions. The reaction not only gave the normal spiro[indene-2,1′-pyrrolo[2,1-a]isoquinoline] derivatives through the normal 1,3-dipolar
cycloaddition reaction but also afforded unique spiro[benzo[f]imidazo[5,1,2-cd]indolizine-4,2′-indene]
derivatives via tandem double [3 + 2] cycloaddition reactions. The
reaction originated from the versatile reactivity of the well-known
heteroaromatic N-ylides and successfully revealed
a new reaction pattern for isoquinolinium ylides in heterocyclic synthesis.
The potential applications of this convenient synthetic protocol in
organic and medicinal chemistry might be significant.

Experimental
Section
General Procedure for the Preparation of Spiro[indene-2,1′-pyrrolo[2,1-a]isoquinolines] 1a–f
A mixture of N-cyanomethylisoquinolinium chloride
(0.5 mmol), 2-arylidene-1,3-indanedione (0.5 mmol), and triethylamine
(0.6 mmol) in dry tetrahydrofuran (15.0 mL) was stirred at room temperature
for 10 h. The solvent was removed at reduced pressure by rotatory
evaporation. The residue was titrated with a mixture of light petroleum
and methylene dichloride to give the pure solid.

1,3-Dioxo-2′-phenyl-1,2′,3,3′-tetrahydro-10b′H-spiro[indene-2,1′-pyrrolo[2,1-a]isoquinoline]-3′-carbonitrile (1a)
Yellow solid, 81%, mp 161–163 °C 1H NMR
(400 MHz, DMSO-d6) δ: 7.78–7.76
(m, 4H, Ar H), 7.20–7.16 (m, 5H, Ar H), 6.94 (t, J = 7.2 Hz, 1H, Ar H), 6.85 (d, J = 7.6 Hz, 1H, Ar
H), 6.59–6.35 (m, 2H, Ar H), 6.23 (d, J =
7.6 Hz, 1H, CH), 5.84 (s, 1H, CH), 5.68 (d, J = 10.0
Hz, 1H, CH), 5.36 (d, J = 7.6 Hz, 1H, CH), 4.29 (d, J = 10.0 Hz, 1H, CH); 13C NMR (100 MHz, DMSO-d6) δ: 198.1, 142.6, 137.0, 134.0, 132.5,
132.1, 129.3, 129.2, 129.0, 128.5, 125.7, 125.2, 125.1, 125.0, 123.2,
119.3, 100.3, 71.1, 71.0, 57.1, 53.9; IR (KBr) υ: 3061, 2924,
2860, 2238, 1810, 1696, 1592, 1491, 1420, 1244, 1033, 854, 760 cm–1; HRMS (ESI) calcd for C27H19N2O2([M + H]+): 403.1441, found:
403.1452.

2′-(2-Methoxyphenyl)-1,3-dioxo-1,2′,3,3′-tetrahydro-10b′H-spiro[indene-2,1′-pyrrolo[2,1-a]isoquinoline]-3′-carbonitrile (1b)
Yellow solid, 84%, mp 162–164 °C; 1H NMR
(400 MHz, DMSO-d6) δ: 7.79–7.71
(m, 4H, Ar H), 7.41 (d, J = 7.2 Hz, 1H, Ar H), 7.15
(t, J = 7.6 Hz, 1H, Ar H), 6.98–6.91 (m, 3H,
Ar H), 6.65 (d, J = 7.6 Hz, 1H, CH), 6.61–6.56
(m, 2H, Ar H), 6.19 (d, J = 7.6 Hz, 1H, Ar H), 5.66
(d, J = 7.6 Hz, 1H, CH), 5.47–5.45 (m 2H,
CH), 4.23–4.22 (m, 1H, CH), 3.12 (s, 3H, OCH3); 13C NMR (100 MHz, DMSO-d6) δ:
198.1, 156.7, 142.2, 136.5, 132.6, 129.7, 128.9, 127.9, 125.6, 125.2,
124.9, 122.9, 120.8, 110.7, 69.8, 68.2, 56.0, 54.6, 49.4; IR (KBr)
υ: 3031, 2928, 2269, 1738, 1704, 1593, 1548, 1540, 1359, 1262,
836, 813, 769, 675 cm–1; HRMS (ESI) calcd for C28H21N2O3([M + H]+): 433.1547, found: 433.1560.

1,3-Dioxo-2′-(p-tolyl)-1,2′,3,3′-tetrahydro-10b′H-spiro[indene-2,1′-pyrrolo[2,1-a]isoquinoline]-3′-carbonitrile (1c)
Yellow solid, 79%, mp 181–183 °C; 1H NMR
(400 MHz, CDCl3) δ: 7.91–7.90 (m, 1H, Ar H),
7.73–7.69 (m, 1H, Ar H), 7.63–7.62 (m, 2H, Ar H), 7.06
(d, J = 8.0 Hz, 2H, Ar H), 6.97–6.92 (m, 3H,
Ar H), 6.83 (d, J = 7.2 Hz, 1H, Ar H), 6.54 (d, J = 7.6 Hz, 1H, Ar H), 6.33 (d, J = 7.2
Hz, 1H, CH), 6.25 (d, J = 7.6 Hz, 1H, Ar H), 5.84
(s, 1H, CH), 5.39 (d, J = 7.2 Hz, 1H, CH), 5.16 (d, J = 10.4 Hz, 1H, CH), 4.29 (d, J = 10.8
Hz, 1H, CH), 2.18 (s, 3H, CH3); 13C NMR (100
MHz, DMSO-d6) δ: 198.2, 142.7, 138.4,
137.1, 134.1, 132.4, 129.7, 129.1, 128.9, 128.4, 125.6, 125.2, 125.1,
125.0, 123.2, 119.3, 100.1, 70.9, 69.4, 57.2, 53.7, 20.9; IR (KBr)
υ: 3059, 2916, 2275, 1740, 1704, 1591, 1562, 1540, 1353, 878,
803, 772, 680 cm–1; HRMS (ESI) calcd for C28H21N2O2([M + H]+): 417.1598,
found: 417.1611.

2′-(4-Bromophenyl)-1,3-dioxo-1,2′,3,3′-tetrahydro-10b′H-spiro[indene-2,1′-pyrrolo[2,1-a]isoquinoline]-3′-carbonitrile (1d)
Yellow solid, 83%, mp 177–179 °C; 1H NMR
(400 MHz, DMSO-d6) δ: 7.78–7.75
(m, 4H, Ar H), 7.41 (d, J = 8.0 Hz, 2H, Ar H), 7.16
(d, J = 8.0 Hz, 2H, Ar H), 6.98 (d, J = 7.2 Hz, 1H, Ar H), 76.89 (d, J = 7.6 Hz, 1H,
Ar H), 6.64–6.60 (m, 2H, Ar H), 6.29 (d, J = 7.6 Hz, 1H, CH), 5.91 (s, 1H, CH), 5.73 (d, J = 10.0 Hz, 1H, CH), 5.44 (d, J = 7.6 Hz, 1H, CH),
4.31 (d, J = 10.4 Hz, 1H, CH),; 13C NMR
(100 MHz, DMSO-d6) δ: 197.7, 142.5,
137.0, 133.9, 132.5, 132.1, 131.9, 130.8, 129.5, 125.9, 125.3, 125.3,
125.0, 123.1, 122.3, 119.0, 101.0, 71.7, 71.7, 57.2, 52.9; IR (KBr)
υ: 3060, 2911, 2231, 1736, 1702, 1593, 1489, 1418, 1248, 766,
718 cm–1; HRMS (ESI) calcd for C27H18BrN2O2([M + H]+): 781.0546,
found: 481.0542.

2′-(4-Chlorophenyl)-1,3-dioxo-1,2′,3,3′-tetrahydro-10b′H-spiro[indene-2,1′-pyrrolo[2,1-a]isoquinoline]-3′-carbonitrile (1e)
Yellow solid, 81%, mp 180–183 °C; 1H NMR
(600 MHz, CDCl3) δ: 7.91–7.90 (m, 1H, Ar H),
7.74–7.73 (m, 1H, Ar H), 7.67–7.62 (m, 2H, Ar H), 7.17–7.13
(m, 4H, Ar H), 6.93 (t, J = 7.2 Hz, 1H, Ar H), 6.84
(d, J = 7.2 Hz, 1H, Ar H), 6.54 (d, J = 7.2 Hz, 1H, Ar H), 6.32 (d, J = 6.6 Hz, 1H, CH),
6.24 (d, J = 7.8 Hz, 1H, Ar H), 5.81 (s, 1H, CH),
5.41 (d, J = 6.0 Hz, 1H, CH), 5.14 (d, J = 10.2 Hz, 1H, CH), 4.28 (d, J = 10.2 Hz, 1H, CH); 13C NMR (100 MHz, DMSO-d6) δ:
199.1, 142.9, 136.0, 136.0, 134.8, 132.3, 131.8, 129.7, 129.6, 129.1,
128.7, 125.4, 125.3, 124.8, 124.8, 123.1, 109.9, 101.1, 70.1, 68.6,
57.7, 53.6; IR (KBr) υ: 3064, 2914, 2240, 1739, 1704, 1590,
1489, 1456, 1276, 1095, 849, 737 cm–1; HRMS (ESI)
calcd for C27H18ClN2O2([M + H]+): 437.1051, found: 437.1045.

2′-(4-(tert-Butyl)phenyl)-1,3-dioxo-1,2′,3,3′-tetrahydro-10b′H-spiro[indene-2,1′-pyrrolo[2,1-a]isoquinoline]-3′-carbonitrile (1f)
Yellow solid, 61%, mp 176–178 °C; 1H NMR
(400 MHz, CDCl3) δ: 7.91–7.90 (m, 1H, Ar H),
7.72–7.69 (m, 1H, Ar H), 7.63–7.62 (m, 2H, Ar H), 7.16
(d, J = 8.4 Hz, 2H, Ar H), 7.09 (d, J = 8.4 Hz, 2H, Ar H), 6.93 (t, J = 7.6 Hz, 1H, Ar
H), 6.83 (d, J = 7.2 Hz, 1H, Ar H), 6.54 (t, J = 7.6 Hz, 1H, Ar H), 6.33 (d, J = 7.2
Hz, 1H, CH), 6.25 (d, J = 7.6 Hz, 1H, Ar H), 5.83
(s, 1H, CH), 5.39 (d, J = 6.8 Hz, 1H, CH), 5.16 (d, J = 10.4 Hz, 1H, CH), 4.30 (d, J = 10.8
Hz, 1H, CH), 1.16 (s, 9H, 3CH3); 13C NMR (100
MHz, DMSO-d6) δ: 198.1, 151.4, 142.7,
137.0, 134.2, 132.4, 129.2, 129.1, 128.3, 126.0, 125.6, 125.2, 125.1,
125.0, 123.2, 119.4, 100.2, 100.1, 71.1, 70.0, 57.4, 53.4, 34.6, 31.2;
IR (KBr) υ: 3057, 2961, 2867, 2257, 1739, 1700, 1595, 1500,
1267, 1084, 951, 805, 762, 721 cm–1; HRMS (ESI)
calcd for C31H27N2O2([M
+ H]+): 459.2067, found: 459.2081.

General Procedure
for the Preparation of Spiro[benzo[f]imidazo[5,1,2-cd]indolizine-4,2′-indenes] 2a–y
A mixture of N-cyanomethylisoquinolinium
chloride (0.5 mmol), aromatic aldehyde
(0.5 mmol), 1,3-indanedione (1.1 mmol), and triethylamine (1.2 mmol)
in acetonitrile (15.0 mL) was stirred at room temperature for 8 h.
The resulting precipitates were collected by filtration and washed
with cold ethanol to give pure products 2a–v for analysis. In the cases of reactions with n-heptanal,
the crude products were subjected to column chromatography with a
mixture of light petroleum and ethyl acetate (v/v = 2:1) as an eluent
to give pure products 2x and 2y for analysis.

2-(1,3-Dioxo-1,3-dihydro-2H-inden-2-ylidene)-3-phenyl-1,2a,3,4a,5,9b-hexahydro-2H-spiro[benzo[f]imidazo[5,1,2-cd]indolizine-4,2′-indene]-1′,3′-dione (2a)
White solid, 83%, mp 249–251 °C; 1H NMR (400 MHz, CDCl3) δ: 10.29 (s, 1H, NH),
7.39 (d, J = 7.6 Hz, 1H, Ar H), 7.76 (t, J = 7.6 Hz, 1H, Ar H), 7.72–7.65 (m, 3H, Ar H), 7.61
(d, J = 6.8 Hz, 1H, Ar H), 7.57–7.51 (m, 2H,
Ar H), 7.44 (d, J = 7.2 Hz, 1H, Ar H), 7.33 (t, J = 7.6 Hz, 1H, Ar H), 7.27 (t, J = 7.6
Hz, 1H, Ar H), 7.19–7.11 (m, 5H, Ar H), 7.01 (d, J = 7.2 Hz, 1H, Ar H), 5.99 (s, 1H, CH), 5.44 (d, J = 6.8 Hz, 1H, CH), 4.66–4.65 (m, 1H, CH), 3.54 (d, J = 10.4 Hz, 1H, CH), 2.93 (t, J = 12.4
Hz, 1H, CH), 2.41–2.36 (m, 1H, CH); 13C NMR (100
MHz, CDCl3) δ: 199.7, 197.5, 194.0, 188.7, 165.7,
142.9, 141.5, 139.9, 139.7, 137.6, 136.1, 135.5, 134.8, 133.2, 132.8,
129.7, 129.1, 129.0, 128.0, 127.9, 127.3, 127.1, 123.1, 123.0, 122.0,
121.2, 100.9, 77.3, 74.5, 67.8, 62.4, 56.3, 30.1; IR (KBr) υ:
3276, 3026, 2916, 1738, 1703, 1570, 1457, 1273, 1087, 859, 739 cm–1; HRMS (ESI) calcd for C36H25N2O4([M + H]+): 549.1809, found:
549.1818.

2-(1,3-Dioxo-1,3-dihydro-2H-inden-2-ylidene)-3-(2-hydroxyphenyl)-1,2a,3,4a,5,9b-hexahydro-2H-spiro[benzo[f]imidazo[5,1,2-cd]indolizine-4,2′-indene]-1′,3′-dione (2b)
White solid, 78%, mp 247–249 °C; 1H NMR (400 MHz, CDCl3) δ: 10.43 (s, 1H, NH),
9.00 (s, 1H, OH), 7.91–7.88 (m, 3H, Ar H), 7.83–7.80
(m, 1H, Ar H), 7.66–7.60 (m, 4H, Ar H), 7.50–7.45 (m,
2H, Ar H), 7.34 (t, J = 7.6 Hz, 1H, Ar H), 7.29–7.26
(m, 1H, Ar H), 7.08 (d, J = 7.6 Hz, 1H, Ar H), 6.90–6.86
(m, 1H, Ar H), 6.74 (t, J = 7.2 Hz, 1H, Ar H), 6.38
(d, J = 8.0 Hz, 1H, Ar H), 5.95 (s, 1H, CH), 5.51–5.50
(m, 1H, CH), 4.64 (d, J = 3.6 Hz, 1H, CH), 3.21 (dd, J1 = 11.6 Hz, J2 =
2.4 Hz, 1H, CH), 2.62–2.55 (m, 1H, CH), 2.35 (dd, J1 = 15.2 Hz, J2 = 2.4 Hz,
1H, CH); 13C NMR (100 MHz, DMSO-d6) δ: 199.7, 197.4, 191.9, 188.2, 167.3, 154.3, 142.3,
141.4, 139.7, 139.5, 136.4, 136.2, 135.4, 133.8, 133.6, 130.4, 129.7,
129.3, 129.1, 128.5, 127.5, 127.2, 125.8, 123.2, 122.9, 121.6, 121.2,
118.7, 114.4, 100.0, 77.7, 73.7, 65.9, 63.4, 48.7, 29.9; IR (KBr)
υ: 3265, 3069, 2910, 1745, 1707, 1566, 1457, 1206, 1139, 997,
862, 741, 694, 655 cm–1; HRMS (ESI) calcd for C36H25N2O5([M + H]+): 565.1758, found: 565.1757.

2-(1,3-Dioxo-1,3-dihydro-2H-inden-2-ylidene)-3-(2-methoxyphenyl)-1,2a,3,4a,5,9b-hexahydro-2H-spiro[benzo[f]imidazo[5,1,2-cd]indolizine-4,2′-indene]-1′,3′-dione (2c)
White solid, 87%, mp 266–268 °C; 1H NMR (400 MHz, DMSO-d6) δ:
10.45 (s, 1H, NH), 8.02 (d, J = 7.2 Hz, 1H, Ar H),
7.94–7.92 (m, 2H, Ar H), 7.85 (t, J = 7.2
Hz, 1H, Ar H), 7.68–7.60 (m, 5H, Ar H), 7.52 (d, J = 6.8 Hz, 1H, Ar H), 7.37 (t, J = 7.6 Hz, 1H, Ar
H), 7.31 (t, J = 7.6 Hz, 1H, Ar H), 7.12–7.10
(m, 2H, Ar H), 6.97 (t, J = 7.6 Hz, 1H, Ar H), 6.58
(d, J = 8.0 Hz, 1H, Ar H), 6.00 (s, 1H, CH), 5.63
(s, 1H, CH), 4.67–4.66 (m, 1H, CH), 3.30–3.28 (m, 1H,
CH), 2.95 (s, 3H, CH3), 2.64 (t, J = 7.2
Hz, 1H, CH), 2.43 (d, J = 10.8 Hz, 1H, CH); 13C NMR (100 MHz, DMSO-d6) δ:
199.4, 197.2, 191.9, 188.4, 167.1, 155.5, 142.1, 141.1, 139.7, 139.5,
136.5, 136.3, 135.4, 133.8, 133.7, 130.4, 129.7, 129.3, 129.1, 128.1,
128.0, 127.4, 127.2, 123.1, 122.9, 121.6, 121.2, 120.5, 110.2, 100.0,
77.8, 73.0, 65.6, 63.1, 54.3, 49.1, 29.8; IR (KBr) υ: 3252,
3072, 2833, 1746, 1708, 1649, 1567, 1492, 1462, 1360, 1275, 1206,
1029, 933, 853, 697 cm–1; HRMS (ESI) calcd for C37H27N2O5([M + H]+): 579.1914, found: 579.1920.

3-(2-Chlorophenyl)-2-(1,3-dioxo-1,3-dihydro-2H-inden-2-ylidene)-1,2a,3,4a,5,9b-hexahydro-2H-spiro[benzo[f]imidazo[5,1,2-cd]indolizine-4,2′-indene]-1′,3′-dione
(2d)
White solid, 89%, mp 264–266 °C; 1H NMR (400 MHz, DMSO-d6) δ:
10.46 (s, 1H, NH), 7.98–7.92 (m, 3H, Ar H), 7.88 (t, J = 7.2 Hz, 1H, Ar H), 7.74 (d, J = 7.6
Hz, 1H, Ar H), 7.70–7.65 (m, 4H, Ar H), 7.56–7.55 (m,
1H, Ar H), 7.38–7.32 (m, 3H, Ar H), 7.17–7.12 (m, 3H,
Ar H), 6.02 (s, 1H, CH), 5.46 (s, 1H, CH), 4.84–4.83 (m, 1H,
CH), 3.37–3.34 (m, 1H, CH), 2.74 (t, J = 12.4
Hz, 1H, CH), 2.52–2.51 (m, 1H, CH); 13C NMR (100
MHz, DMSO-d6) δ: 199.9, 196.9, 191.6,
188.5, 166.0, 141.9, 141.8, 139.7, 139.5, 137.3, 136.8, 136.7, 135.3,
133.9, 133.7, 133.4, 131.0, 130.3, 129.9, 129.3, 129.2, 129.0, 128.7,
127.2, 127.0, 123.6, 123.1, 121.6, 121.3, 99.9, 78.0, 76.1, 65.8,
63.4, 52.1, 29.7; IR (KBr) υ: 3279, 3069, 2907, 2836, 1746,
1709, 1659, 1572, 1461, 1436, 1205, 1036, 891, 850, 792, 685 cm–1; HRMS (ESI) calcd for C36H24ClN2O4([M + H]+): 583.1419, found:
583.1421.

3-(2-Bromophenyl)-2-(1,3-dioxo-1,3-dihydro-2H-inden-2-ylidene)-1,2a,3,4a,5,9b-hexahydro-2H-spiro[benzo[f]imidazo[5,1,2-cd]indolizine-4,2′-indene]-1′,3′-dione
(2e)
White solid, 85%, mp 270–272 °C; 1H NMR (600 MHz, CDCl3) δ: 10.21 (s, 1H, NH),
8.42–8.37 (m, 2H, Ar H), 7.97 (d, J = 7.2
Hz, 1H, Ar H), 7.83–7.73 (m, 5H, Ar H), 7.63–7.55 (m,
3H, Ar H), 7.46 (d, J = 7.8 Hz, 1H, Ar H), 7.36 (t, J = 7.8 Hz, 1H, Ar H), 7.30 (t, J = 7.2
Hz, 1H, Ar H), 7.26–7.24 (m, 1H, Ar H), 7.03 (d, J = 7.2 Hz, 1H, Ar H), 6.00 (s, 1H, CH), 5.39–5.38 (m, 1H,
CH), 4.65–4.64 (m, 1H, CH), 3.56 (d, J = 12.0
Hz, 1H, CH), 2.91 (t, J = 13.2 Hz, 1H, CH), 2.40
(d, J = 15.0 Hz, 1H, CH); 13C NMR (100
MHz, DMSO-d6) δ: 200.0, 196.9, 191.5,
188.5, 165.9, 142.1, 141.9, 139.8, 139.6, 138.5, 137.2, 136.8, 135.4,
133.9, 133.7, 132.3, 131.4, 130.3, 129.9, 129.3, 129.2, 128.9, 127.5,
127.2, 124.9, 123.7, 123.1, 121.6, 121.3, 100.0, 78.1, 76.8, 65.8,
63.3, 54.7, 29.7; IR (KBr) υ: 3278, 3066, 2914, 2836, 1741,
1703, 1584, 1464, 1431, 1265, 1132, 852, 746 cm–1; HRMS (ESI) calcd for C36H24BrN2O4([M + H]+): 627.0914, found: 627.0900.

2-(1,3-Dioxo-1,3-dihydro-2H-inden-2-ylidene)-3-(m-tolyl)-1,2a,3,4a,5,9b-hexahydro-2H-spiro[benzo[f]imidazo[5,1,2-cd]indolizine-4,2′-indene]-1′,3′-dione
(2f)
White solid, 86%, mp 233–235 °C; 1H NMR (400 MHz, CDCl3) δ: 10.23 (s, 1H, NH),
7.93 (d, J = 7.6 Hz, 1H, Ar H), 7.76 (t, J = 7.2 Hz, 1H, Ar H), 7.72–7.69 (m, 2H, Ar H), 7.66
(d, J = 8.0 Hz, 1H, Ar H), 7.62 (d, J = 6.8 Hz, 1H, Ar H), 7.57–7.50 (m, 1H, Ar H), 7.44 (d, J = 7.6 Hz, 1H, Ar H), 7.32 (t, J = 7.6
Hz, 1H, Ar H), 7.28–7.25 (m, 1H, Ar H), 7.04–7.00 (m,
3H, Ar H), 6.92–6.89 (m, 2H, Ar H), 6.00 (s, 1H, CH), 5.45
(d, J = 3.6 Hz, 1H, CH), 4.63 (d, J = 4.0 Hz, 1H, CH), 3.55–3.52 (m, 1H, CH), 2.99–2.92
(m, 1H, CH), 2.39 (dd, J1 = 15.2 Hz, J2 = 2.0 Hz, 1H, CH), 2.20 (s, 3H, CH3); 13C NMR (100 MHz, CDCl3) δ: 199.8,
197.5, 193.9, 188.7, 165.7, 143.0, 141.6, 139.9, 139.7, 137.5, 137.4,
136.0, 135.4, 134.9, 133.2, 132.8, 129.7, 129.1, 129.0, 128.5, 127.9,
127.8, 127.2, 125.1, 123.1, 123.0, 122.0, 121.2, 100.9, 77.3, 77.0,
76.7, 74.4, 67.8, 62.3, 56.3, 30.1, 21.4; IR (KBr) υ: 3273,
3099, 3018, 2918, 1741, 1706, 1570, 1489, 1461, 1365, 1278, 1137,
1062, 934, 868, 730, 700, 653 cm–1; HRMS (ESI) calcd
for C37H26KN2O4([M + K]+): 601.1524, found: 601.1527.

2-(1,3-Bioxo-1,3-dihydro-2H-inden-2-ylidene)-3-(3-fluorophenyl)-1,2a,3,4a,5,9b-hexahydro-2H-spiro[benzo[f]imidazo[5,1,2-cd]indolizine-4,2′-indene]-1′,3′-dione (2g)
White solid, 81%, mp 259–261 °C; 1H NMR (400 MHz, DMSO-d6) δ:
10.24 (s, 1H, NH), 7.95 (d, J = 7.6 Hz, 1H, Ar H),
7.82–7.70 (m, 4H, Ar H), 7.63–7.61 (m, 1H, Ar H), 7.58–7.54
(m, 2H, Ar H), 7.44 (d, J = 7.6 Hz, 1H, Ar H), 7.33
(t, J = 7.6 Hz, 1H, Ar H), 7.29–7.25 (m, 1H,
Ar H), 7.16–7.12 (m, 1H, Ar H), 7.02–6.93 (m, 3H, Ar
H), 6.85–6.80 (m, 1H, Ar H), 5.98 (s, 1H, CH), 5.39 (d, J = 3.6 Hz, 1H, CH), 4.64 (d, J = 4.4 Hz,
1H, CH), 3.51 (dd, J1 = 11.6 Hz, J2 = 2.4 Hz, 1H, CH), 2.94–2.87 (m, 1H,
CH), 2.37 (dd, J1 = 15.2 Hz, J2 = 2.8 Hz, 1H, CH); 13C NMR (100 MHz, CDCl3) δ: 199.4, 197.3, 193.8, 188.8, 165.3, 162.4 (d, J = 244.5 Hz), 142.8, 141.4, 140.4, 140.3, 139.9, 139.7,
134.6, 133.3, 133.0, 129.5, 129.5, 129.2, 129.1, 128.0, 127.3, 123.7,
123.3, 123.2, 121.9, 121.2, 115.2 (d, J = 22.6 Hz),
114.1 (d, J = 20.9 Hz), 109.9, 100.8, 77.2, 74.3,
67.6, 62.7, 55.6, 30.1; IR (KBr) υ: 3280, 3067, 3020, 2916,
2838, 1742, 1709, 1659, 1589, 1488, 1202, 1090, 959, 828, 739 cm–1; HRMS (ESI) calcd for C36H24FN2O4([M + H]+): 567.1715, found:
567.1709.

2-(1,3-Dioxo-1,3-dihydro-2H-inden-2-ylidene)-3-(3-nitrophenyl)-1,2a,3,4a,5,9b-hexahydro-2H-spiro[benzo[f]imidazo[5,1,2-cd]indolizine-4,2′-indene]-1′,3′-dione (2h)
White solid, 82%, mp 252–254 °C; 1H NMR (400 MHz, CDCl3) δ: 10.18 (s, 1H, NH),
8.16–8.15 (m, 1H, Ar H), 8.04–8.01 (m, 1H, Ar H), 7.97
(d, J = 7.6 Hz, 1H, Ar H), 7.84–7.80 (m, 1H,
Ar H), 7.78–7.74 (m, 1H, Ar H), 7.72–7.71 (m, 1H, Ar
H), 7.60–7.53 (m, 4H, Ar H), 7.45 (d, J =
7.2 Hz, 1H, Ar H), 7.41–7.33 (m, 2H, Ar H), 7.30–7.26
(m, 1H, Ar H), 7.01 (d, J = 7.6 Hz, 1H, Ar H), 5.99
(s, 1H, CH), 5.44 (d, J = 3.6 Hz, 1H, CH), 4.73 (d, J = 4.0 Hz, 1H, CH), 3.53 (dd, J1 = 8.0 Hz, J2 = 2.4 Hz, 1H, CH), 2.91–4.84
(m, 1H, CH), 2.37 (dd, J1 = 14.8 Hz, J2 = 2.4 Hz, 1H, CH); 13C NMR (100
MHz, CDCl3) δ: 198.8, 197.2, 193.7, 189.0, 164.8,
147.8, 142.5, 141.3, 140.2, 139.8, 139.6, 136.6, 136.1, 134.4, 134.3,
133.4, 133.1, 129.4, 129.2, 129.0, 128.0, 127.4, 123.4, 123.3, 123.2,
122.2, 121.9, 121.3, 100.8, 77.2, 74.3, 67.6, 63.2, 55.0, 30.1; IR
(KBr) υ: 3282, 3068, 2911, 2835, 1743, 1708, 1660, 1569, 1529,
1462, 1203, 994, 831, 737 cm–1; HRMS (ESI) calcd
for C36H24N3O6([M + H]+): 594.1660, found: 594.1651.

2-(1,3-Dioxo-1,3-dihydro-2H-inden-2-ylidene)-3-(p-tolyl)-1,2a,3,4a,5,9b-hexahydro-2H-spiro[benzo[f]imidazo[5,1,2-cd]indolizine-4,2′-indene]-1′,3′-dione
(2i)
White solid, 92%, mp 233–235 °C; 1H NMR (400 MHz, DMSO-d6) δ:
10.48 (s, 1H, NH), 7.97–7.95 (m, 1H, Ar H), 7.92–7.86
(m, 3H, Ar H), 7.68–7.62 (m, 4H, Ar H), 7.50 (d, J = 6.4 Hz, 1H, Ar H), 7.34 (t, J = 7.2 Hz, 1H, Ar
H), 7.27 (t, J = 6.4 Hz, 1H, Ar H), 7.07 (d, J = 7.2 Hz, 1H, Ar H), 6.92–6.90 (m, 3H, Ar H), 5.96–5.95
(m, 1H, CH), 5.47–5.45 (m, 1H, CH), 4.37 (d, J = 4.0 Hz, 1H, CH), 3.18 (dd, J1 = 12.0
Hz, J2 = 2.4 Hz, 1H, CH), 2.64–2.57
(m, 1H, CH), 2.45–2.42 (m, 1H, CH), 2.16 (s, 3H, CH3); 13C NMR (100 MHz, DMSO-d6) δ: 200.5, 196.9, 192.0, 188.3, 166.7, 142.7, 141.3, 139.6,
139.5, 137.5, 136.7, 135.9, 135.7, 135.1, 133.9, 133.7, 130.3, 129.6,
129.4, 129.2, 128.7, 128.0, 127.3, 123.7, 123.3, 121.7, 121.2, 100.0,
77.3, 74.6, 67.6, 63.0, 55.4, 29.8, 21.0; IR (KBr) υ: 3275,
3018, 2918, 1738, 1704, 1569, 1459, 1357, 1274, 1135, 861, 740 cm–1; HRMS (ESI) calcd for C37H27N2O4([M + H]+): 563.1965, found:
563.1979.

3-(4-(Bimethylamino)phenyl)-2-(1,3-dioxo-1,3-dihydro-2H-inden-2-ylidene)-1,2a,3,4a,5,9b-hexahydro-2H-spiro[benzo[f]imidazo[5,1,2-cd]indolizine-4,2′-indene]-1′,3′-dione (2j)
White solid, 73%, mp 262–264 °C; 1H NMR (400 MHz, CDCl3) δ: 10.35 (s, 1H, NH),
7.92–7.91 (m, 1H, Ar H), 7.74–7.69 (m, 4H, Ar H), 7.62–7.61
(m, 1H, Ar H), 7.53–7.52 (m, 2H, Ar H), 7.43–7.41 (m,
1H, Ar H), 7.32–7.30 (m, 2H, Ar H), 7.04–7.01 (m, 3H,
Ar H), 6.54–6.51 (m, 2H, Ar H), 5.98 (s, 1H, CH), 5.34 (s,
1H, CH), 4.60 (s, 1H, CH), 3.51 (d, J = 12.4 Hz,
1H, CH), 2.96 (t, J = 10.4 Hz, 1H, CH), 2.84 (s,
6H, 2CH3), 2.37 (d, J = 13.2 Hz, 1H, CH); 13C NMR (100 MHz, CDCl3) δ: 200.1, 197.9,
194.1, 188.6, 166.0, 149.2, 143.1, 141.7, 139.9, 139.7, 135.9, 135.2,
135.0, 133.1, 132.7, 129.8, 129.1, 129.0, 128.8, 127.9, 127.2, 125.3,
123.2, 122.9, 122.0, 121.1, 112.1, 101.0, 77.1, 75.2, 68.0, 62.1,
56.0, 40.4, 30.2; IR (KBr) υ: 3270, 3071, 2903, 2832, 1744,
1708, 1665, 1568, 1520, 1459, 1362, 1340, 1246, 1058, 858, 743, 693
cm–1; HRMS (ESI) calcd for C38H29N3NaO4([M + Na]+): 614.2050, found:
614.2041.

3-(4-Bromophenyl)-2-(1,3-dioxo-1,3-dihydro-2H-inden-2-ylidene)-1,2a,3,4a,5,9b-hexahydro-2H-spiro[benzo[f]imidazo[5,1,2-cd]indolizine-4,2′-indene]-1′,3′-dione
(2k)
White solid, 81%, mp 278–281 °C; 1H NMR (400 MHz, DMSO-d6) δ:
10.46 (s, 1H, NH), 7.98–7.89 (m, 4H, Ar H), 7.73–7.71
(m, 1H, Ar H), 7.62–7.57 (m, 4H, Ar H), 7.36–7.30 (m,
3H, Ar H), 7.28 (t, J = 7.6 Hz, 1H, Ar H), 7.08–6.95
(m, 3H, Ar H), 5.93 (s, 1H, CH), 5.48 (s, 1H, CH), 4.36–4.35
(m, 1H, CH), 3.19 (d, J = 10.4 Hz, 1H, CH), 2.58
(t, J = 12.4 Hz, 1H, CH), 2.45–2.43 (m, 1H,
CH); 13C NMR (100 MHz, DMSO-d6) δ: 200.0, 196.9, 191.9, 191.9, 191.9, 188.5, 188.4, 188.4,
166.3, 142.6, 141.3, 138.4, 137.6, 136.9, 135.0, 133.9, 133.9, 133.8,
133.8, 133.8, 131.0, 130.4, 130.3, 129.7, 129.4, 129.2, 127.3, 123.8,
123.3, 120.0, 100.0, 77.4, 74.3, 67.5, 63.2, 54.9, 40.4, 40.2, 39.9,
29.9; IR (KBr) υ: 3279, 3066, 2902, 1738, 1704, 1569, 1488,
1279, 1137, 1003, 934, 862, 744 cm–1; HRMS (ESI)
calcd for C36H23BrKN2O4([M + K]+): 665.0473, found: 665.0460.

3-(4-Chlorophenyl)-2-(1,3-dioxo-1,3-dihydro-2H-inden-2-ylidene)-1,2a,3,4a,5,9b-hexahydro-2H-spiro[benzo[f]imidazo[5,1,2-cd]indolizine-4,2′-indene]-1′,3′-dione
(2l)
White solid, 91%, mp 269–272 °C; 1H NMR (400 MHz, DMSO-d6) δ:
10.50 (s, 1H, NH), 8.02–8.00 (m, 2H, Ar H), 7.97–7.94
(m, 2H, Ar H), 7.75 (d, J = 7.2 Hz, 1H, Ar H), 7.70–7.68
(m, 2H, Ar H), 7.54 (d, J = 6.8 Hz, 1H, Ar H), 7.42–7.40
(m, 1H, Ar H), 7.33–7.29 (m, 2H, Ar H), 7.24–7.22 (m,
3H, Ar H), 7.12–7.08 (m, 2H, Ar H), 5.98 (s, 1H, CH), 5.54–5.50
(m, 1H, CH), 4.42–4.41 (m, 1H, CH), 3.24 (d, J = 10.8 Hz, 1H, CH), 2.64 (t, J = 12.4 Hz, 1H, CH),
2.49–2.47 (m, 1H, CH); 13C NMR (100 MHz, DMSO-d6) δ: 200.0, 196.9, 191.9, 188.4, 166.3,
142.6, 141.3, 139.7, 139.5, 138.0, 137.6, 136.9, 135.0, 133.9, 133.7,
131.4, 130.3, 130.1, 129.7, 129.3, 129.2, 128.1, 127.3, 123.8, 123.3,
121.7, 121.3, 100.0, 77.4, 74.4, 67.6, 63.2, 54.9, 29.9; IR (KBr)
υ: 3287, 3042, 2938, 1739, 1704, 1661, 1568, 1487, 1283, 1141,
1020, 936, 897, 732 cm–1; HRMS (ESI) calcd for C36H24ClN2O4([M + H]+): 583.1419, found: 583.1421.

3-(4-(tert-Butyl)phenyl)-2-(1,3-dioxo-1,3-dihydro-2H-inden-2-ylidene)-1,2a,3,4a,5,9b-hexahydro-2H-spiro[benzo[f]imidazo[5,1,2-cd]indolizine-4,2′-indene]-1′,3′-dione (2m)
White solid, 81%, mp 255–257 °C; 1H NMR (400 MHz, CDCl3) δ: 10.35 (s, 1H, NH),
7.92 (d, J = 7.6 Hz, 1H, Ar H), 7.76–7.73
(m, 1H, Ar H), 7.71–7.65 (m, 2H, Ar H), 7.63–7.61 (m,
1H, Ar H), 7.58–7.56 (m, 1H, Ar H), 7.55–7.50 (m, 2H,
Ar H), 7.44 (d, J = 7.2 Hz, 1H, Ar H), 7.33 (t, J = 7.2 Hz, 1H, Ar H), 7.29–7.25 (m, 1H, Ar H), 7.15–7.06
(m, 4H, Ar H), 7.03 (d, J = 7.6 Hz, 1H, Ar H), 6.01
(s, 1H, CH), 5.40–5.38 (m, 1H, CH), 4.63 (d, J = 4.0 Hz, 1H, CH), 3.55 (dd, J1 = 12.0
Hz, J2 = 2.4 Hz, 1H, CH), 3.03–2.96
(m, 1H, CH), 2.40 (dd, J1 = 15.6 Hz, J2 = 2.4 Hz, 1H, CH), 1.20 (s, 9H, 3CH3); 13C NMR (100 MHz, CDCl3) δ: 199.7,
197.6, 197.6, 194.0, 188.8, 165.7, 149.5, 143.1, 141.6, 139.9, 139.6,
135.8, 135.3, 135.0, 134.4, 133.1, 132.8, 129.7, 129.2, 129.0, 127.9,
127.7, 127.2, 124.9, 122.9, 122.0, 121.2, 100.9, 77.3, 74.7, 68.0,
61.8, 56.4, 34.3, 31.2, 30.1; IR (KBr) υ: 3280, 3063, 3019,
2960, 2872, 1741, 1703, 1569, 1461, 1356, 1274, 1136, 931, 824, 742
cm–1; HRMS (ESI) calcd for C40H33N2O4([M + H]+): 605.2435, found:
605.2432.

2-(1,3-Dioxo-1,3-dihydro-2H-inden-2-ylidene)-3-(4-nitrophenyl)-1,2a,3,4a,5,9b-hexahydro-2H-spiro[benzo[f]imidazo[5,1,2-cd]indolizine-4,2′-indene]-1′,3′-dione (2n)
White solid, 79%, mp 265–267 °C; 1H NMR (400 MHz, DMSO-d6) δ:
10.48 (s, 1H, NH), 8.12–8.00 (m, 4H, Ar H), 7.98–7.92
(m, 3H, Ar H), 7.74 (d, J = 7.6 Hz, 1H, Ar H), 7.70–7.65
(m, 3H, Ar H), 7.52 (d, J = 6.8 Hz, 1H, Ar H), 7.44–7.43
(m, 1H, Ar H), 7.38 (t, J = 7.2 Hz, 1H, Ar H), 7.32
(t, J = 7.6 Hz, 1H, Ar H), 7.11 (d, J = 7.6 Hz, 1H, Ar H), 6.00 (s, 1H, CH), 5.66 (s, 1H, CH), 4.56 (d, J = 3.6 Hz, 1H, CH), 3.26–3.25 (m, 1H, CH), 2.62
(t, J = 12.0 Hz, 1H, CH), 2.52–2.51 (m, 1H,
CH); 13C NMR (100 MHz, DMSO-d6) δ: 199.4, 196.7, 191.8, 188.6, 166.0, 147.0, 146.5, 142.4,
141.2, 139.6, 139.5, 137.8, 137.1, 134.9, 133.9, 133.8, 130.2, 129.7,
129.5, 129.4, 129.2, 127.3, 124.0, 123.4, 123.3, 121.7, 121.3, 99.9,
77.4, 74.0, 67.7, 63.6, 54.7, 29.9; IR (KBr) υ: 3245, 3017,
2900, 2832, 1741, 1704, 1571, 1571, 1460, 1206, 1050, 896, 789, 698
cm–1; HRMS (ESI) calcd for C36H23KN3O4([M + K]+): 632.1218, found:
632.1216.

3-(4-Chloro-2-hydroxyphenyl)-2-(1,3-dioxo-1,3-dihydro-2H-inden-2-ylidene)-1,2a,3,4a,5,9b-hexahydro-2H-spiro[benzo[f]imidazo[5,1,2-cd]indolizine-4,2′-indene]-1′,3′-dione (2o)
White solid, 72%, mp 240–242 °C; 1H NMR (400 MHz, DMSO-d6) δ:
10.45 (s, 1H, NH), 9.44 (s, 1H, OH), 7.98–7.92 (m, 3H, Ar H),
7.88 (t, J = 7.2 Hz, 1H, Ar H), 7.75–7.73
(m, 1H, Ar H), 7.69–7.66 (m, 3H, Ar H), 7.55–7.54 (m,
2H, Ar H), 7.37 (t, J = 7.6 Hz, 1H, Ar H), 7.31 (t, J = 7.6 Hz, 1H, Ar H), 7.11 (d, J = 7.6
Hz, 1H, Ar H), 7.00–6.97 (m, 1H, Ar H), 6.45 (d, J = 8.8 Hz, 1H, Ar H), 5.98 (s, 1H, CH), 5.59 (s, 1H, CH), 4.61 (d, J = 3.6 Hz, 1H, CH), 3.24–3.21 (m, 1H, CH), 2.63–2.56
(m, 1H, CH), 2.40–2.37 (m, 1H, CH); 13C NMR (100
MHz, DMSO-d6) δ: 199.4, 197.5, 191.8,
188.5, 167.0, 153.3, 142.2, 141.3, 139.7, 136.6, 136.5, 135.2, 133.7,
130.4, 129.8, 129.3, 129.2, 128.3, 127.3, 127.2, 123.3, 123.1, 122.6,
121.6, 115.9, 100.0, 77.8, 73.4, 65.7, 63.7, 48.3, 29.9; IR (KBr)
υ: 3351, 3304, 3058, 2926, 1741, 1705, 1667, 1570, 1490, 1462,
1203, 1033, 928, 869, 787, 740, 700, 659 cm–1; HRMS
(ESI) calcd for C36H24ClN2O5([M + H]+): 599.1368, found: 599.1364.

2-(1,3-Dioxo-1,3-dihydro-2H-inden-2-ylidene)-3-(furan-2-yl)-1,2a,3,4a,5,9b-hexahydro-2H-spiro[benzo[f]imidazo[5,1,2-cd]indolizine-4,2′-indene]-1′,3′-dione (2p)
White solid, 69%, mp 221–223 °C; 1H NMR (400 MHz, DMSO-d6) δ:
10.54 (s, 1H, NH), 8.08–8.04 (m, 3H, Ar H), 7.96–7.92
(m, 2H, Ar H), 7.75–7.71 (m, 3H, Ar H), 7.62–7.60 (m,
1H, Ar H), 7.39–7.34 (m, 2H, Ar H), 7.26–7.25 (m, 1H,
Ar H), 7.12–7.11 (m, 1H, Ar H), 6.38–6.34 (m, 2H, Ar
H), 5.97 (s, 1H, CH), 5.56 (s, 1H, CH), 4.50–4.48 (m, 1H, CH),
3.16–3.10 (m, 1H, CH), 2.60–2.58 (m, 1H, CH), 2.50–2.46
(m, 1H, CH); 13C NMR (100 MHz, DMSO-d6) δ: 199.3, 195.7, 191.5, 188.2, 165.4, 152.3, 142.0,
141.2, 140.6, 139.2, 139.0, 137.2, 136.4, 134.3, 133.6, 133.4, 129.8,
129.2, 129.0, 128.8, 126.9, 123.5, 122.9, 121.3, 120.9, 110.5, 106.4,
99.6, 76.6, 72.5, 65.6, 62.7, 47.7, 39.5, 29.2; IR (KBr) υ:
3278, 3069, 2913, 2831, 1744, 1707, 1680, 1593, 1564, 1462, 1244,
1135, 888, 697 cm–1; HRMS (ESI) calcd for C34H23N2O5([M + H]+): 539.1601, found: 539.1620.

2-(1,3-Dioxo-1,3-dihydro-2H-inden-2-ylidene)-3-(thiophen-2-yl)-1,2a,3,4a,5,9b-hexahydro-2H-spiro[benzo[f]imidazo[5,1,2-cd]indolizine-4,2′-indene]-1′,3′-dione (2q)
White solid, 78%, mp 233–235 °C; 1H NMR (400 MHz, DMSO-d6) δ:
10.55 (s, 1H, NH), 8.06–8.04 (m, 1H, Ar H), 7.99–7.97
(m, 2H, Ar H), 7.94 (d, J = 8.0 Hz, 1H, Ar H), 7.82
(d, J = 8.0 Hz, 1H, Ar H), 7.69–7.67 (m, 3H,
Ar H), 7.59–7.57 (m, 3H, Ar H), 7.37 (t, J = 8.0 Hz, 1H, Ar H), 7.32 (t, J = 7.6 Hz, 1H, Ar
H), 7.21 (d, J = 4.4 Hz, 1H, Ar H), 7.11 (d, J = 7.6 Hz, 1H, Ar H), 6.87–6.86 (m, 2H, Ar H), 5.99
(s, 1H, CH), 5.53 (s, 1H, CH), 4.67 (d, J = 4.0 Hz,
1H, CH), 3.21–3.18 (m, 1H, CH), 2.62–2.59 (m, 1H, CH),
2.50–2.48 (m, 1H, CH); 13C NMR (100 MHz, DMSO-d6) δ: 200.0, 196.2, 192.0, 188.3, 165.8,
142.8, 142.0, 141.4, 139.6, 139.5, 137.6, 136.8, 134.8, 134.0, 133.8,
130.2, 129.6, 129.4, 129.2, 127.3, 126.9, 125.5, 124.1, 123.8, 123.3,
121.7, 121.3, 100.1, 77.1, 75.6, 67.6, 63.0, 50.3, 29.8; IR (KBr)
υ: 3277, 3068, 2915, 2836, 1742, 1705, 1568, 1462, 1245, 1203,
1060, 892, 738, 692 cm–1; HRMS (ESI) calcd for C34H23N3O2S ([M + H]+): 555.1373, found: 555.1383.

2-(1,3-Dioxo-1,3-dihydro-2H-inden-2-ylidene)-3-(pyridin-2-yl)-1,2a,3,4a,5,9b-hexahydro-2H-spiro[benzo[f]imidazo[5,1,2-cd]indolizine-4,2′-indene]-1′,3′-dione (2r)
White solid, 83%, mp 270–272 °C; 1H NMR (400 MHz, DMSO-d6) δ:
10.55 (s, 1H, NH), 8.07 (d, J = 7.6 Hz, 1H, Ar H),
8.01–7.94 (m, 4H, Ar H), 7.89 (d, J = 6.8
Hz, 1H, Ar H), 7.75 (d, J = 7.6 Hz, 1H, Ar H), 7.70–7.64
(m, 4H, Ar H), 7.55 (d, J = 6.8 Hz, 1H, Ar H), 7.37
(t, J = 7.6 Hz, 1H, Ar H), 7.30 (t, J = 7.6 Hz, 1H, Ar H), 7.13–7.09 (m, 2H, Ar H), 5.97 (s, 1H,
CH), 5.91 (s, 1H, CH), 4.73 (d, J = 4.0 Hz, 1H, CH),
3.15–3.11 (m, 1H, CH), 2.48–2.45 (m, 1H, CH), 2.42–2.38
(m, 1H, CH); 13C NMR (100 MHz, DMSO-d6) δ: 199.7, 197.7, 192.0, 188.7, 167.0, 158.6, 147.9,
147.9, 142.8, 141.4, 139.6, 139.5, 137.0, 136.5, 136.4, 134.7, 134.0,
133.8, 130.3, 129.6, 129.4, 129.2, 127.3, 123.9, 122.9, 122.4, 121.9,
121.7, 121.3, 100.0, 77.0, 77.0, 71.4, 67.5, 63.1, 55.8, 55.7, 29.8,
29.8; IR (KBr) υ: 3271, 3062, 2925, 1745, 1710, 1648, 1568,
1466, 1338, 1212, 935, 682 cm–1; HRMS (ESI) calcd
for C35H24N3O4 ([M + H]+): 550.1761, found: 550.1769.

2-(1,3-Dioxo-1,3-dihydro-2H-inden-2-ylidene)-3-(pyridin-3-yl)-1,2a,3,4a,5,9b-hexahydro-2H-spiro[benzo[f]imidazo[5,1,2-cd]indolizine-4,2′-indene]-1′,3′-dione (2s)
White solid, 76%, mp 255–257 °C; 1H NMR (400 MHz, DMSO-d6) δ:
10.50 (s, 1H, NH), 8.33–8.32 (m, 1H, Ar H), 8.25–8.24
(m, 1H, Ar H), 8.02 (d, J = 7.2 Hz, 1H, Ar H), 7.99–7.92
(m, 3H, Ar H), 7.74–7.68 (m, 5H, Ar H), 7.55–7.53 (m,
1H, Ar H), 7.38 (t, J = 7.6 Hz, 1H, Ar H), 7.32 (t, J = 7.2 Hz, 1H, Ar H), 7.26–7.24 (m, 1H, Ar H), 7.12
(d, J = 7.6 Hz, 1H, Ar H), 5.99 (s, 1H, CH), 5.58
(s, 1H, CH), 4.43 (d, J = 3.2 Hz, 1H, CH), 3.28 (d, J = 12.0 Hz, 1H, CH), 2.66 (t, J = 12.0
Hz, 1H, CH), 2.54–2.51 (m, 1H, CH); 13C NMR (100
MHz, DMSO-d6) δ: 199.7, 197.0, 191.8,
188.5, 166.1, 149.4, 148.1, 142.5, 141.3, 139.7, 139.5, 137.7, 137.1,
135.8, 135.0, 134.6, 133.9, 133.8, 130.2, 129.7, 129.4, 129.2, 127.3,
123.9, 123.3, 123.2, 121.7, 121.3, 99.9, 77.4, 74.2, 67.5, 63.3, 53.1,
29.8; IR (KBr) υ: 3284, 3070, 2969, 2916, 1741, 1704, 1571,
1484, 1202, 1089, 932, 713, 682, 618 cm–1; HRMS
(ESI) calcd for C35H24N3O4([M + H]+): 550.1761, found: 550.1783.

2-(1,3-Dioxo-1,3-dihydro-2H-inden-2-ylidene)-3-(pyridin-4-yl)-1,2a,3,4a,5,9b-hexahydro-2H-spiro[benzo[f]imidazo[5,1,2-cd]indolizine-4,2′-indene]-1′,3′-dione (2t)
White solid, 74%, mp 265–267 °C; 1H NMR (400 MHz, DMSO-d6) δ:
10.50 (s, 1H, NH), 8.37–8.36 (m, 2H, Ar H), 8.05 (d, J = 6.8 Hz, 1H, Ar H), 8.01–7.95 (m, 3H, Ar H), 7.75
(t, J = 7.2 Hz, 1H, Ar H), 7.69–7.66 (m, 3H,
Ar H), 7.55–7.53 (m, 1H, Ar H), 7.38 (t, J = 7.2 Hz, 1H, Ar H), 7.32 (t, J = 7.2 Hz, 1H, Ar
H), 7.12–7.10 (m, 3H, Ar H), 5.98 (s, 1H, CH), 5.66 (s, 1H,
CH), 4.41 (d, J = 3.2 Hz, 1H, CH), 3.24 (d, J = 11.2 Hz, 1H, CH), 2.59 (t, J = 11.6
Hz, 1H, CH), 2.49–2.48 (m, 1H, CH); 13C NMR (100
MHz, DMSO-d6) δ: 199.5, 196.6, 191.8,
188.6, 166.1, 149.6, 147.8, 142.5, 141.2, 139.6, 137.8, 137.1, 134.9,
133.9, 133.8, 130.2, 129.7, 129.4, 129.2, 127.3, 124.0, 123.4, 123.2,
121.7, 121.3, 99.9, 77.3, 73.0, 67.4, 63.4, 54.2, 29.8; IR (KBr) υ:
3293, 3071, 3038, 2901, 2834, 1742, 1705, 1668, 1567, 1461, 1203,
1140, 1054, 892, 815, 740, 680 cm–1; HRMS (ESI)
calcd for C35H24N3O4 ([M
+ H]+): 550.1761, found: 550.1783.

3-Benzoyl-2-(1,3-dioxo-1,3-dihydro-2H-inden-2-ylidene)-1,2a,3,4a,5,9b-hexahydro-2H-spiro[benzo[f]imidazo[5,1,2-cd]indolizine-4,2′-indene]-1′,3′-dione (2u)
White solid, 85%, mp 284–286 °C; 1H NMR (400 MHz, DMSO-d6) δ:
10.68 (s, 1H, NH), 8.18 (d, J = 7.6 Hz, 1H, Ar H),
8.10–8.05 (m, 3H, Ar H), 7.99–7.91 (m, 4H, Ar H), 7.82
(d, J = 6.4 Hz, 1H, Ar H), 7.63–7.58 (m, 6H,
Ar H), 7.52 (t, J = 7.2 Hz, 2H, Ar H), 7.41 (t, J = 7.2 Hz, 2H, Ar H), 7.30 (d, J = 7.6
Hz, 1H, Ar H), 6.26 (s, 1H, CH), 6.10 (s, 1H, CH), 5.27 (d, J = 3.6 Hz, 1H, CH), 3.40–3.37 (m, 1H, CH), 2.68–2.65
(m, 1H, CH), 2.61–2.57 (m, 1H, CH); 13C NMR (100
MHz, DMSO-d6) δ: 199.5, 196.7, 193.8,
191.8, 189.4, 166.4, 141.5, 140.8, 139.8, 139.4, 137.5, 136.9, 136.5,
134.6, 134.0, 133.9, 133.3, 130.2, 129.8, 129.4, 129.1, 128.8, 128.2,
127.3, 123.6, 123.2, 121.8, 121.3, 99.7, 77.6, 69.7, 64.9, 64.7, 55.8,
29.6; IR (KBr) υ: 3239, 3065, 2913, 2828, 1739, 1708, 1653,
1580, 1461, 1266, 1144, 792, 704, 637 cm–1; HRMS
(ESI) calcd for C37H25N2O5 ([M + H]+): 577.1758, found: 577.1765.

6-Bromo-3-(4-chlorophenyl)-2-(1,3-dioxo-1,3-dihydro-2H-inden-2-ylidene)-1,2a,3,4a,5,9b-hexahydro-2H-spiro[benzo[f]imidazo[5,1,2-cd]indolizine-4,2′-indene]-1′,3′-dione (2v)
White solid, 81%, mp 266–268 °C; 1H NMR (600 MHz, DMSO-d6) δ:
10.56 (s, 1H, NH), 8.04 (d, J = 7.8 Hz, 1H, Ar H),
8.01 (d, J = 7.8 Hz, 1H, Ar H), 7.97 (d, J = 7.8 Hz, 1H, Ar H), 7.93 (d, J = 7.2
Hz, 1H, Ar H), 7.73 (d, J = 7.8 Hz, 1H, Ar H), 7.71–7.67
(m, 4H, Ar H), 7.56 (d, J = 7.2 Hz, 1H, Ar H), 7.38
(t, J = 7.8 Hz, 1H, Ar H), 7.24–7.23 (m, 2H,
Ar H), 7.12–7.11 (m, 1H, Ar H), 6.00 (s, 1H, CH), 5.51 (s,
1H, CH), 4.40 (d, J = 3.6 Hz, 1H, CH), 3.29 (dd, J1 = 11.4 Hz, J2 =
2.4 Hz, 1H, CH), 2.61–2.58 (m, 1H, CH), 2.53–2.52 (m,
1H, CH); 13C NMR (100 MHz, DMSO-d6) δ: 199.5, 196.8, 191.6, 188.4, 165.9, 134.6, 132.8,
131.4, 130.1, 129.6, 128.9, 127.9, 124.3, 123.8, 123.2, 100.0, 77.0,
74.5, 67.1, 62.2, 55.4, 30.9; IR (KBr) υ: 3288, 3066, 2927,
1738, 1702, 1652, 1571, 1492, 1452, 1280, 1136, 1012, 892, 819, 779,
698 cm–1; HRMS (ESI) calcd for C36H22BrClN2NaO4 ([M + Na]+):
683.0344, found: 683.0351.

6-Bromo-2-(1,3-dioxo-1,3-dihydro-2H-inden-2-ylidene)-3-(4-nitrophenyl)-1,2a,3,4a,5,9b-hexahydro-2H-spiro[benzo[f]imidazo[5,1,2-cd]indolizine-4,2′-indene]-1′,3′-dione (2w)
White solid, 83%, mp 275–277 °C; 1H NMR (400 MHz, DMSO-d6) δ:
10.59 (s, 1H, NH), 8.08–8.03 (m, 4H, Ar H), 7.99 (t, J = 7.2 Hz, 1H, Ar H), 7.93 (t, J = 7.2
Hz, 1H, Ar H), 7.74 (d, J = 7.6 Hz, 1H, Ar H), 7.67–7.65
(m, 3H, Ar H), 7.61–7.60 (m, 2H, Ar H), 7.40–7.35 (m,
3H, Ar H), 5.99 (s, 1H, CH), 5.62 (s, 1H, CH), 4.53 (d, J = 3.6 Hz, 1H, CH), 3.31 (dd, J1 = 11.2
Hz, J2 = 2.4 Hz, 1H, CH), 2.61–2.58
(m, 1H, CH), 2.48–2.44 (m, 1H, CH); 13C NMR (100
MHz, DMSO-d6) δ: 199.2, 196.8, 165.8,
147.0, 146.5, 142.4, 141.2, 139.7, 137.8, 137.2, 134.6, 133.7, 133.0,
129.7, 129.7, 129.1, 124.4, 124.1, 123.4, 123.3, 121.3, 100.1, 78.0,
77.9, 77.9, 74.5, 67.5, 62.7, 55.4, 31.1; IR (KBr) υ: 3288,
3074, 2912, 1744, 1704, 1658, 1578, 1518, 1421, 1214, 1011, 942, 839,
706, 690 cm–1; HRMS (ESI) calcd for C36H22BrKN3O6 ([M + K]+):
710.0324, found: 710.0319.

2-(1,3-Dioxo-1,3-dihydro-2H-inden-2-ylidene)-3-hexyl-1,2a,3,4a,5,9b-hexahydro-2H-spiro[benzo[f]imidazo[5,1,2-cd]indolizine-4,2′-indene]-1′,3′-dione (2x)
White solid, 70%, mp 275–277 °C; 1H NMR (400 MHz, DMSO-d6) δ:
10.52 (s, 1H, NH), 8.10–8.03 (m, 4H, Ar H), 7.86 (t, J = 8.0 Hz, 1H, Ar H), 7.71–7.70 (m, 4H, Ar H), 7.35
(t, J = 7.6 Hz, 1H, Ar H), 7.28 (d, J = 7.2 Hz, 1H, Ar H), 7.08 (d, J = 7.2 Hz, 1H, Ar
H), 5.86(s, 1H, CH), 4.70 (s, 1H, CH), 3.19 (d, J = 12.0 Hz, 1H, CH), 2.97 (d, J = 11.6 Hz, 1H, CH),
2.70–2.69 (m, 1H, CH), 2.49–2.46 (m, 1H, CH), 2.37 (d, J = 10.8 Hz, 1H, CH), 1.99–1.91 (m, 1H, CH), 1.10–1.05
(m, 2H, CH), 0.96–0.94 (m, 4H, CH), 0.79–0.78 (m, 1H,
CH), 0.69 (t, J = 5.6 Hz, 3H, CH3), 0.51–0.50
(m, 1H, CH); 13C NMR (100 MHz, DMSO-d6) δ: 200.8, 198.3, 192.3, 188.9, 167.1, 142.3, 140.3,
139.7, 139.3, 137.6, 137.1, 134.7, 134.0, 133.8, 130.2, 129.4, 129.1,
127.3, 123.9, 123.3, 121.7, 121.3, 100.2, 76.9, 76.7, 65.0, 64.3,
49.3, 31.1, 31.0, 29.6, 28.4, 28.1, 21.8, 14.1; IR (KBr) υ:
3237, 3071, 2952, 2849, 1741, 1703, 1647, 1593, 1493, 1359, 1334,
1273, 1203, 1002, 897, 785, 737, 685 cm–1; HRMS
(ESI) calcd for C36H32N2NaO4([M + Na]+): 579.2254, found: 579.2254.

6-Bromo-2-(1,3-dioxo-1,3-dihydro-2H-inden-2-ylidene)-3-hexyl-1,2a,3,4a,5,9b-hexahydro-2H-spiro[benzo[f]imidazo[5,1,2-cd]indolizine-4,2′-indene]-1′,3′-dione (2y)
White solid, 63%, mp 251–253 °C; 1H NMR (400 MHz, DMSO-d6) δ:
10.54 (s, 1H, NH), 8.12–8.04 (m, 4H, Ar H), 7.95 (t, J = 7.2 Hz, 1H, Ar H), 7.72–7.70 (m, 4H, Ar H), 7.62
(d, J = 7.6 Hz, 1H, Ar H), 7.33 (t, J = 7.2 Hz, 1H, Ar H), 5.86(s, 1H, CH), 4.71 (s, 1H, CH), 3.21 (d, J = 11.6 Hz, 1H, CH), 3.01 (d, J = 11.2
Hz, 1H, CH), 2.68–2.66 (m, 1H, CH), 2.41 (d, J = 15.0 Hz, 1H, CH), 2.33 (d, J = 12.4 Hz, 1H, CH),
1.98–1.95 (m, 1H, CH), 1.09–1.06 (m, 2H, CH), 0.96–0.92
(m, 4H, CH), 0.80–0.78 (m, 1H, CH), 0.70 (t, J = 5.6 Hz, 3H, CH3), 0.52–0.50 (m, 1H, CH); 13C NMR (100 MHz, DMSO-d6) δ:
200.6, 198.2, 192.2, 188.9, 166.9, 142.2, 140.4, 139.7, 139.3, 137.7,
137.2, 134.2, 134.0, 133.8, 133.0, 132.9, 129.4, 129.1, 124.5, 124.0,
123.3, 121.7, 121.3, 100.4, 76.7, 64.8, 63.8, 49.7, 31.1, 31.0, 30.8,
28.4, 28.1, 21.8, 14.1; IR (KBr) υ: 3247, 3071, 2925, 2853,
1742, 1707, 1669, 1569, 1451, 1359, 1276, 1215, 1090, 953, 833, 777,
696, 652 cm–1; HRMS (ESI) calcd for C36H32BrN2NaO4([M + H]+):
635.1540, found: 635.1544.

Supporting Information Available
The Supporting Information
is available free of charge on the ACS Publications website at DOI: 10.1021/acsomega.7b01391.1H
and 13C NMR spectra for all
pure products (PDF)

X-ray crystal data for 2i (CCDC 1552741) and X-ray crystal
data for 2l (CCDC 1552742) (CIF)



Supplementary Material
ao7b01391_si_001.pdf

 ao7b01391_si_002.cif

 The authors
declare no competing financial interest.

Acknowledgments
We are
grateful to the National Natural Science Foundation
of China (No. 21572196) and the Priority Academic Program Development
of Jiangsu Higher Education Institutions for financial support (No.
BK2013016). The Analytical Center of Yangzhou University is acknowledged
for analytical assistance.
==== Refs
References
a Sliwa W. 
Cycloaddition reactions
of pyridinium ylides and oxidopyridiniums . Heterocycles 
1996 , 43 , 2005 –2029 . 10.3987/REV-96-478 . b Jacobs J. ; Van Hende E. ; Claessens S. ; De Kimpe N. 
Pyridinium ylides in
heterocyclic synthesis . Curr. Org. Chem. 
2011 , 15 , 1340 –1362 . 10.2174/138527211795378209 . c Kakehi A. 
Reactions of pyridinium
N-ylides and their related pyridinium salts . Heterocycles 
2012 , 85 , 1529 –1577 . 10.3987/REV-12-735 . d Bull J. A. ; Mousseau J. J. ; Pelletier G. ; Charette A. B. 
Synthesis of Pyridine and Dihydropyridine Derivatives
by Regio- and Stereoselective Addition to N-Activated Pyridines . Chem. Rev. 
2012 , 112 , 2642 –2713 . 10.1021/cr200251d .22352938 
a Katritzky A. R. ; Grzeskowiak N. E. ; Alvarez-Builla J. 
Preparation
of tetrahydroindolizines from pyridinium and isoquinolinium ylides . J. Chem. Soc., Perkin Trans. 1 
1981 , 1180 –1185 . 10.1039/p19810001180 . b Tsuge O. ; Kanemasa S. ; Takenaka S. 
Stereochemical study
on 1,3-dipolar cycloaddition reactions of heteroaromatic N-ylides
with symmetrically substituted cis and trans olefins . Bull. Chem. Soc. Jpn. 
1985 , 58 , 3137 –3157 . 10.1246/bcsj.58.3137 . c Tsuge O. ; Kanemasa S. ; Takenaka S. 
Stereochemical
study on 1,3-dipolar cycloaddition reactions of heteroaromatic N-ylides
with unsymmetrically substituted olefinic dipolarophiles . Bull. Chem. Soc. Jpn. 
1985 , 58 , 3320 –3336 . 10.1246/bcsj.58.3320 . d Ruano J. L. ; Fraile A. ; Martin M. R. ; Gonzalez G. ; Fajardo C. ; Martin-Castro A. M. 
Asymmetric
synthesis of pyrrolo[2,1-a]isoquinoline derivatives by 1,3-dipolar
cycloadditions of stabilized isoquinolinium N-ylides with sulfinyl
dipolarophiles . J. Org. Chem. 
2011 , 76 , 3296 –3305 . 10.1021/jo200191c .21381764  e Allgäuer D. S. ; Mayr H. 
Electrophilicities of 1,2-Disubstituted Ethylenes . Eur. J. Org. Chem. 
2014 , 2014 , 2956 –2963 . 10.1002/ejoc.201301779 . f Allgäuer D. S. ; Mayer P. ; Mayr H. 
Nucleophilicity Parameters of Pyridinium Ylides and Their Use in
Mechanistic Analyses . J. Am. Chem. Soc. 
2013 , 135 , 15216 –15224 . 10.1021/ja407885h .24020381  g Allgäuer D. S. ; Mayr H. 
One-Pot Two-Step Synthesis of 1-(Ethoxycarbonyl)indolizines via Pyridinium
Ylides . Eur. J. Org. Chem. 
2013 , 2013 , 6379 –6388 . 10.1002/ejoc.201300784 .
a Zhang X.-c. ; Huang W.-y. 
A one-step approach to 1-(fluoroalkyl)indolizine
derivatives . Synthesis 
1999 , 1999 , 51 –54 . 10.1055/s-1999-3675 . b Zhu S. Z. ; Qin C. Y. ; Wang Y. L. ; Chu Q. L. 
Preparation of 1-(trifluoroacetyl)indolizines
and their derivatives via cycloaddition of pyridinium N-ylides with
4-ethoxy-1,1,1-trifluorobut-3-en-2-one . J. Fluorine
Chem. 
1999 , 99 , 183 –187 . 10.1016/S0022-1139(99)00145-1 . c Peng W. ; Zhu S. 
Reactions of N-benzyl-pyridinium
or -isoquinolinium ylides with ethyl 3-fluoro-3-(fluoroalkyl)acrylates
to give fluoroalkyl-substituted indolizine and pyrrolo[2,1-a]isoquinoline
derivatives . J. Chem. Soc., Perkin Trans. 1 
2001 , 3204 –3210 . 10.1039/b103586j . d Wu K. ; Chen Q.-Y. 
Synthesis of fluorinated indolizines and 4H-pyrrolo[1,2-a]benzimidazoles
via 1,3-dipolar cycloaddition of fluoroalkenes to N-ylides . Synthesis 
2003 , 0035 –0040 . 10.1055/s-2003-36246 . e Liu Y. ; Sun J. W. 
Copper(II)-Catalyzed Synthesis of
Benzo[f]pyrido[1,2-a]indole-6,11-dione Derivatives via Naphthoquinone
Difunctionalization Reaction . J. Org. Chem. 
2012 , 77 , 1191 –1197 . 10.1021/jo2023312 .22185652  f Wang F. ; Shen Y. ; Hu H. ; Wang X. ; Wu H. ; Liu Y. 
Copper(II)-Catalyzed Indolizines Formation Followed by Dehydrogenative
Functionalization Cascade to Synthesize 1-Bromoindolizines . J. Org. Chem. 
2014 , 79 , 9556 –9566 . 10.1021/jo501626b .25233481  g Brioche J. ; Meyer C. ; Cossy J. 
Synthesis
of 2-Aminoindolizines by 1,3-Dipolar Cycloaddition of Pyridinium Ylides
with Electron-Deficient Ynamides . Org. Lett. 
2015 , 17 , 2800 –2803 . 10.1021/acs.orglett.5b01205 .25988320 
a Gupta R. B. ; Franck R. W. 
Cycloadditions of
isoquinolinium
salts: evidence for a two-step mechanism in a stereocontrolled synthesis
of substituted tetralins . J. Am. Chem. Soc. 
1987 , 109 , 5393 –5403 . 10.1021/ja00252a015 . b Fernández N. ; Carrillo L. ; Vicario J. L. ; Badia D. ; Reyes E. 
Organocatalytic
enantioselective (3+2) cycloaddition using stable azomethine ylides . Chem. Commun. 
2011 , 47 , 12313 –12315 . 10.1039/c1cc15671c . c Ruano J. L.
G. ; Fraile A. ; Martin M. R. ; Gonzalez G. ; Fajardo C. ; Martin-Castro A. M. 
Asymmetric
synthesis of pyrrolo[2,1-a]isoquinoline derivatives by 1,3-dipolar
cycloadditions of stabilized isoquinolinium N-ylides with sulfinyl
dipolarophiles . J. Org. Chem. 
2011 , 76 , 3296 –3305 . 10.1021/jo200191c .21381764  d Bakshi D. ; Singh A. 
Transition-Metal-Free Synthesis of Nitrogen Containing Heterocycles
With Fully Substituted N-fused Pyrrole Rings . Asian J. Org. Chem. 
2016 , 5 , 70 –73 . 10.1002/ajoc.201500324 . e Yang W. J. ; Yuan C. H. ; Liu Y. ; Mao B. M. ; Sun Z. H. ; Guo H. C. 
[4+3] Cycloaddition of Phthalazinium
Dicyanomethanides with Azoalkenes Formed in Situ: Synthesis of Triazepine
Derivatives . J. Org. Chem. 
2016 , 81 , 7597 –7603 . 10.1021/acs.joc.6b01296 .27467599 
a Pilli R. A. ; Rodrigues J. A. R. ; Kascheres A. 
Reaction of
N-(p-tolylsulfonyl)diphenylcyclopropenimine with pyridinium and isoquinolinium
ylides . J. Org. Chem. 
1983 , 48 , 1084 –1091 . 10.1021/jo00155a031 . b Fang X. ; Wu Y. M. ; Deng J. ; Wang S. W. 
Synthesis of monofluorinated
indolizines and their derivatives by the 1,3-dipolar reaction of N-ylides
with fluorinated vinyl tosylates . Tetrahedron 
2004 , 60 , 5487 –5493 . 10.1016/j.tet.2004.04.012 . c Liu Y. ; Hu H. Y. ; Liu Q. J. ; Hu H. W. ; Xu J. H. 
Synthesis of polycyclic indolizine derivatives via one-pot tandem
reactions of N-ylides with dichloro substituted α,β-unsaturated
carbonyl compounds . Tetrahedron 
2007 , 63 , 2024 –2033 . 10.1016/j.tet.2006.12.050 . d An J. ; Yang Q. Q. ; Wang Q. ; Xiao W. J. 
Direct
synthesis of pyrrolo[2,1-a]isoquinolines by 1,3-dipolar cycloaddition
of stabilized isoquinolinium N-ylides with vinyl sulfonium salts . Tetrahedron Lett. 
2013 , 54 , 3834 –3837 . 10.1016/j.tetlet.2013.05.053 . e Xu X. ; Zavalij P. Y. ; Doyle M. P. 
Catalytic
Asymmetric Syntheses of Quinolizidines by Dirhodium-Catalyzed Dearomatization
of Isoquinolinium/Pyridinium Methylides-The Role of Catalyst and Carbene
Source . J. Am. Chem. Soc. 
2013 , 135 , 12439 –12447 . 10.1021/ja406482q .23889041  f Li F. ; Chen J. F. ; Hou Y. D. ; Li Y. J. ; Wu X. Y. ; Tong X. F. 
1,3-Dipolar Cycloadditions of 4-Acetoxy Allenoates:
Access to 2,3-Dihydropyrazoles, 2,3-Dihydroisoxazoles, and Indolizines . Org. Lett. 
2015 , 17 , 5376 –5379 . 10.1021/acs.orglett.5b02724 .26469697 
a Yamaguchi R. ; Nakayasu T. ; Hatano B. ; Nagura T. ; Kozima S. ; Fujita K. 
Facile addition reactions
of allylsilanes
to quinolines and isoquinolines activated by chloroformate ester and
a catalytic amount of triflate ion . Tetrahedron 
2001 , 57 , 109 –118 . 10.1016/S0040-4020(00)00993-5 . b Lin C. H. ; Jhang J. F. ; Yang D. Y. 
One-Pot Synthesis
of Coumarin-Based Oxazabicyclic and Oxazatricyclic Compounds and Their
Fluorescence Redox Switching Properties . Org.
Lett. 
2009 , 11 , 4064 –4067 . 10.1021/ol901505e .19678618  c Lin C. H. ; Chen J. R. ; Yang D. Y. 
Syntheses of Quaternary
Carbon-Containing Oxazatricycle and Spiropyran Libraries via Multicomponent
Reactions and Their Molecular Switching Properties . J. Comb. Chem. 
2010 , 12 , 119 –124 . 10.1021/cc900127g .19860449  d Cabrera-Pardo J. R. ; Chai D. I. ; Kozmina S. A. 
Silver-Promoted
Benzannulations of Siloxyalkynes with Pyridinium and Isoquinolinium
Salts . Adv. Synth. Catal. 
2013 , 355 , 2495 –2498 . 10.1002/adsc.201300443 .24653670  e Liu L. J. ; Yan C. G. 
Efficient Synthesis of Complex Oxazatricycles via Three-Component
Reaction of Isoquinolinium Salts, Acetone and Cyclic Diketones . J. Heterocycl. Chem. 
2015 , 52 , 1513 –1517 . 10.1002/jhet.2201 .
a Wang Q. F. ; Hui L. ; Hou H. ; Yan C. G. 
Synthesis
of Zwitterionic Salts of Pyridinium-Meldrum Acid and Barbiturate through
Unique Four-component Reactions . J. Comb. Chem. 
2010 , 12 , 260 –265 . 10.1021/cc900161z .20092329  b Hou H. ; Zhang Y. ; Yan C. G. 
One-pot synthesis of 4-substituted
isoquinolinium zwitterionic salts by metal-free C-H bond activation . Chem. Commun. 
2012 , 48 , 4492 –4494 . 10.1039/c2cc30708a .
Liu R. ; Shi R. G. ; Sun J. ; Yan C. G. 
A [3+2]-[4+2]-[3+2]
cycloaddition sequence of isoquinolinium ylide . Org. Chem. Front. 
2017 , 4 , 354 –357 . 10.1039/C6QO00615A .
a Fang J. ; Yan C. G. 
Synthesis of 6a,6b,13,13a-tetrahydro-6H-5-oxa-12a-azadibenzo[a,g]fluorene
derivatives via cycloaddition reactions of isoquinolinium salts with
3-nitrochromenes . Mol. Diversity 
2014 , 18 , 91 –99 . 10.1007/s11030-013-9489-z . b Wu L. ; Sun J. ; Yan C. G. 
Facile synthesis of spiro[indoline-3,3′-pyrrolo[1,2-a]quinolines]
and spiro[indoline-3,1′-pyrrolo[2,1-a]isoquinolines] via 1,3-dipolar
cycloaddition reactions of heteroaromatic ammonium salts with 3-phenacylideneoxindoles . Org. Biomol. Chem. 
2012 , 10 , 9452 –9436 . 10.1039/c2ob26849c .23117483  c Wang X. H. ; Yan C. G. 
Facile synthesis
of spiro[indane-2,1′-pyrrolo[2,1-a]isoquinolines] via three-component
reaction of isoquinolinium salts, indane-1,3-dione, and isatins . Synthesis 
2014 , 46 , 1059 –1066 . 10.1055/s-0033-1340815 . d Sun J. ; Shen G. L. ; Huang Y. ; Yan C. G. 
Formation
of diverse polycyclic spirooxindoles via three-component reaction
of isoquinolinium salts, isatins and malononitrile . Sci. Rep. 
2017 , 7 , 4102410.1038/srep41024 .28106130 
a Belei D. ; Abuhaie C. ; Bicu E. ; Jones P. G. ; Hopf H. ; Birsa L. M. 
A direct synthesis
of octahydropyrrolo[2,1,5-cd]indolizin-6-one derivatives . Synlett 
2012 , 23 , 545 –548 . 10.1055/s-0031-1290337 . b Hopf H. ; Jones P. G. ; Nicolescu A. ; Bicu E. ; Birsa L. M. ; Belei D. 
A Facile Synthesis
of Pechmann Dyes . Chem. – Eur. J. 
2014 , 20 , 5565 –5568 . 10.1002/chem.201400329 .24700785  c Liu R. Z. ; Wang X. Y. ; Sun J. ; Yan C. G. 
A facile
synthesis of tricyclic skeleton of alkaloid 261C by double [3+2] cycloaddition
of pyridinium ylide . Tetrahedron Lett. 
2015 , 56 , 6711 –6714 . 10.1016/j.tetlet.2015.10.049 .
a Kanemasa S. ; Takenaka S. ; Watanabe H. ; Tsuge O. 
Tandem 1,3-dipolar cycloadditions of pyridinium or isoquinolinium
methylides with olefinic dipolarophiles leading to cycl[3.2.2]azines.
Enamine route as a new generation method of azomethine ylides . J. Org. Chem. 
1989 , 54 , 420 –424 . 10.1021/jo00263a030 . b Xu J. H. ; Zheng S. C. ; Zhang J. W. ; Liu X. Y. ; Tan B. 
Construction of Tropane Derivatives by the Organocatalytic Asymmetric
Dearomatization of Isoquinolines . Angew. Chem.,
Int. Ed. 
2016 , 55 , 11834 –11839 . 10.1002/anie.201605736 .
a Voskressensky L. G. ; Kulikova L. N. ; Listratova A. V. ; Borisov R. S. ; Kukaniev M. A. ; Varlamov A. V. 
A novel
cascade
Kroehnke condensation - an intramolecular nucleophilic cyclization
approach toward annulated chromenes . Tetrahedron
Lett. 
2010 , 51 , 2269 –2270 . 10.1016/j.tetlet.2010.02.102 . b Voskressensky L. G. ; Festa A. A. ; Sokolova E. A. ; Varlamov A. V. 
Synthesis of chromeno[2′,3′:4,5]imidazo[2,1-a]isoquinolines
via a novel domino reaction of isoquinoline-derived immonium salts.
Scope and limitations . Tetrahedron 
2012 , 68 , 5498 –5504 . 10.1016/j.tet.2012.04.087 . c Voskressensky L. G. ; Sokolova E. A. ; Festa A. A. ; Varlamov A. V. 
A novel domino condensation-intramolecular nucleophilic
cyclization approach towards annulated thiochromenes . Tetrahedron Lett. 
2013 , 54 , 5172 –5173 . 10.1016/j.tetlet.2013.07.040 .

